Antistreptokinase antibodies: implications for thrombolysis in a region with endemic streptococcal infection: Table 1

Abstract

Anti-SK antibodies are highly prevalent in SK naive indigenous patients presenting with the acute coronary syndrome. Streptokinase should not be used for thrombolysis in populations with endemic group A streptococcal infection.